Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )
6 Jun 2016

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany
First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
6 Jun 2016

Testing the safety and efficacy of the PD-L1 antibody durvalumab

Dr Christophe Massard - Institut Gustave Roussy, Paris, France
Testing the safety and efficacy of the PD-L1 antibody durvalumab ( Dr Christophe Massard - Institut Gustave Roussy, Paris, France )
6 Jun 2016

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016

Novel antibody helps patients with advanced gastric cancer live longer

Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Novel antibody helps patients with advanced gastric cancer live longer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
5 Jun 2016

Antibody drug conjugate shows early promise in small cell lung cancer

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA
Antibody drug conjugate shows early promise in small cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )
5 Jun 2016

Novel antibody helps patients with advanced gastric cancer live longer

Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Novel antibody helps patients with advanced gastric cancer live longer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
5 Jun 2016

Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy

Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
5 Jun 2016

Novel daratumumab-based regimen slows multiple myeloma progression

Prof Antonio Palumbo - University of Torina, Turin, Italy
Novel daratumumab-based regimen slows multiple myeloma progression ( Prof Antonio Palumbo - University of Torina, Turin, Italy )
5 Jun 2016

Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma

Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
5 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation